Original Research

Characteristics and mutation analysis of Ph-positive leukemia patients with T315I mutation receiving tyrosine kinase inhibitors

Xu PP, Guo D, Shao XY, Peng MX, Chen B

OncoTargets and Therapy 2017, 10:4731-4738

Published Date: 25 September 2017